Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening Products

New MRI Technique Could Mean Fewer Breast Biopsies In High-Risk Women
A University of Wisconsin-Madison biomedical engineer and colleagues have developed a method that, applied in MRI scans of the breast, could spare some women with increased breast cancer risk the pain and stress of having to endure a biopsy of a questionable lump or lesion.
generic viagra online
House Democrats Set To Move Bill After Accord With Blue Dogs, Liberals Objecting
House Democrats on Wednesday made a deal with fiscally conservative Blue Dog Democrats on a health reform bill that "would reduce the overall cost of the package and ensure more funding for rural hospitals, concessions that could allow the Energy and Commerce Committee to finish its consideration of the legislation," The Washington Post reports. The deal will be considered on the House floor no earlier than September, according to several lawmakers. House lawmakers plan to conclude their markup of the legislation in the Energy Committee Thursday.
News of the day
Picks For NIH Head, Surgeon General Side With Obama On Reproductive Issues, Despite Faith
Francis Collins, President Obama"s pick to head NIH, and Regina Benjamin, Obama"s surgeon general nominee, have spoken publicly about their religious beliefs but also have expressed views on issues such as embryonic stem cell research that conflict with church teachings, USA Today reports. Collins, who headed the Human Genome Project, is an evangelical Christian who supports the use of human embryonic stem cells in some medical research. Focus on the Family in a newsletter lauded Obama"s choice of an evangelical to lead NIH but said that abortion-rights opponents cannot support Collins" views, "particularly since he supports destructive human embryonic stem cell research."Benjamin is a Roman Catholic and sits on the board of the Catholic Health Association. She also is active in her local church and received a papal medal in 2006. According to USA Today, Catholic leaders from her native state of Alabama say they have not heard Benjamin voice support for abortion rights. The Bayou La Batre, La., medical clinic that she oversees does not perform abortions. Bill Donohue, president of the Catholic League, initially expressed support for Benjamin"s nomination, saying, "Her tireless and selfless efforts are a model for all physicians." He later said that he opposes any possible support she might give "mandated abortion coverage" in health reform.The White House has said that Benjamin agrees with Obama "on reproductive issues." Retired archbishop Oscar Lipscomb, who nominated Benjamin for the papal medal, said, "She is a practicing Catholic and faithful and, to the best of my knowledge, in all those questions that have arisen so far, there has never been a conflict in her practice and in her conversation with regard to what the church expects of medical practitioners." Former Surgeon General David Satcher, who taught Benjamin at Morehouse School of Medicine, said, "While the religion of the surgeon general may very well influence his or her ... approach, the message has to be the public health science," adding, "It"s not a religious message. It"s a public health science message."Emilie Townes, associate dean of academic affairs for Yale Divinity School, said that Obama"s choices represent his aim to "break the mold" of traditional politics, adding that Collins and Benjamin are examples of "big tent" evangelicalism and Catholicism (Banks, USA Today, 8/3).
Sexual Health

Z-Cube And Yissum Research Development Company Ltd. Sign A Licensing Agreement

Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain. The technology was invented by Professor Elka Touitou from the Department of Pharmaceutics, Faculty of Medicine, at the Hebrew University of Jerusalem. Under the terms of the agreement, Z-Cube has received the worldwide exclusive right to develop and commercialize the technology for pain applications and will sponsor a research program to be conducted by Prof. Touitou and her group. Z-Cube has also received the right to grant sublicenses. Yissum will receive license fees, milestones and royalty payments. "We are pleased to partner with Z-Cube, a world leader in the commercialization of drug delivery technologies," said Yaacov Michlin, CEO of Yissum. "Our novel drug delivery system has the potential to enable relief of both mild and severe pain quickly and efficiently." The work of Prof. Touitou, a worldwide authority in the drug delivery field, focuses on the design of novel carriers for enhanced drug absorption and efficiency. Two start-up companies have been established and are active in the development of various novel pharmaceutical products that are based on her previously-developed innovative technologies. "This innovative drug delivery system is a powerful tool enabling the development of improved medicines for the treatment of pain," said Lorenzo Pradella, Ph.D., Business and Operational Development Director of Z-Cube. "Patients suffering from pain will benefit from this new approach that promises to generate upgraded and easier to use therapeutics." In 2007, the worldwide market for pain management products (excluding over-the-counter products) was approximately $ 4.2 billion, representing one of the largest pharmaceutical segments. The expectation is that the demand for prescription pain management products will continue to grow due to favorable demographics, increasing incidence of chronic pain conditions, and heightened awareness of physicians for the need to treat pain. Improved pain treatment includes not only the discovery and marketing of new chemical entities, such as pain killers, but also the development of new delivery systems devoted to reducing side effects, increasing safety and improving compliance. Yissum Ltd.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009